Cargando…
Dosimetric implications of the potential radionuclidic impurities in (153)Sm-DOTMP
Thehuman internal dosimetry of the radionuclidic impurities of samarium-153 in a new bone-seeking radiopharmaceutical, (153)Sm-1,4,7,10tetraazacyclododecanetetramethylenephosponic acid ((153)Sm-DOTMP), has been estimated from preclinical data. The effective dose from the impurities in lower-specific...
Autores principales: | Wendt, Richard E., Ketring, Alan R., Frank, R. Keith, Simón, Jaime |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896376/ https://www.ncbi.nlm.nih.gov/pubmed/35452906 http://dx.doi.org/10.1016/j.apradiso.2022.110246 |
Ejemplares similares
-
Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [$^{153}$Sm]Sm-DOTA-TATE
por: Vermeulen, Koen, et al.
Publicado: (2022) -
Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [(153)Sm]Sm-DOTA-TATE
por: Vermeulen, Koen, et al.
Publicado: (2022) -
Production of Sm-153 With Very High Specific Activity for Targeted Radionuclide Therapy
por: Van de Voorde, Michiel, et al.
Publicado: (2021) -
Production of Sm-153 With Very High Specific Activity for Targeted Radionuclide Therapy
por: Van de Voorde, Michiel, et al.
Publicado: (2021) -
Production and quality control (177)Lu (NCA)—DOTMP as a potential agent for bone pain palliation
por: Salek, Nafise, et al.
Publicado: (2016)